Clinical Trial Update: Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating how fructose affects metabolism and MRI biomarkers in nonalcoholic fatty liver disease; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Snippet

Sponsor: Manal F Abdelmalek | Conditions: Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Status: TERMINATED | Results posted: 2022-08-31